Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey

Andersson A, Hawranek C, Öfverholm A, Ehrencrona H, Grill K, Hajdarevic S et al (2020) Public support for healthcare-mediated disclosure of hereditary cancer risk information: results from a population-based survey in Sweden. Hereditary Cancer Clin Pract 18(1). https://doi.org/10.1186/s13053-020-00151-0

Armstrong K (2005) Racial differences in the Use of BRCA1/2 testing among women with a family history of breast or ovarian Cancer. JAMA 293(14):1729. https://doi.org/10.1001/jama.293.14.1729

Article  CAS  PubMed  Google Scholar 

Attorney - General’s Department (2022) Privacy Act (1988) Australia. Act No. 44, 2020. Federal Register of Legislation, Australian Government. https://www.legislation.gov.au/Details/C2022C00199. Accessed 28 Oct 2022

Baroutsou V, Underhill-Blazey ML, Appenzeller-Herzog C, Katapodi MC (2021) Interventions facilitating family communication of genetic testing results and Cascade screening in hereditary breast/ovarian cancer or Lynch Syndrome: a systematic review and meta-analysis. Cancers 13(4):925. https://doi.org/10.3390/cancers13040925

Article  PubMed  PubMed Central  Google Scholar 

Cella D, Hughes C, Peterman A, Chang C, Peshkin B, Schwartz M et al (2002) A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol 21(6):564–572. https://doi.org/10.1037/0278-6133.21.6.564

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention (CDC) (2021) Health Insurance Portability and accountability act of 1996 (HIPAA). Centers for Disease Control and Prevention. https://www.cdc.gov/phlp/php/resources/health-insurance-portability-and-accountability-act-of-1996-hipaa.html?CDC_AAref_Val=https://www.cdc.gov/phlp/publications/topic/hipaa.html. Accessed 23 May 2021

Cohen S, Leininger A (2014) The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Application Clin Genet 147. https://doi.org/10.2147/tacg.s51483

Coleman M, Muir C, Ménégoz F (1992) Confidentiality in the cancer registry. Br J Cancer 66(6):1138–1149. https://doi.org/10.1038/bjc.1992.424

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daly M, Montgomery S, Bingler R, Ruth K (2016) Communicating genetic test results within the family: is it lost in translation? A survey of relatives in the randomized six-step study. Fam Cancer 15(4):697–706. https://doi.org/10.1007/s10689-016-9889-1

Article  PubMed  PubMed Central  Google Scholar 

Daly M, Pal T, Berry M, Buys S, Dickson P, Domchek S et al (2021) Genetic/Familial High-Risk Assessment: breast, ovarian, and pancreatic, Version 2.2021, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw 19(1):77–102. https://doi.org/10.6004/jnccn.2021.0001

Article  CAS  PubMed  Google Scholar 

Dean M, Tezak AL, Johnson S, Pierce JK, Weidner A, Clouse K, Pal T, Cragun D (2021) Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers. Patient Educ Couns 104(4):720–725. https://doi.org/10.1016/j.pec.2020.12.019

Article  PubMed  PubMed Central  Google Scholar 

Delikurt T, Williamson G, Anastasiadou V, Skirton H (2014) A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet 23(6):739–745. https://doi.org/10.1038/ejhg.2014.180

Article  PubMed  PubMed Central  Google Scholar 

DeMarco T, Peshkin B, Mars B, Tercyak K (2004) Patient satisfaction with Cancer Genetic Counseling: a psychometric analysis of the genetic counseling satisfaction scale. J Genet Couns 13(4):293–304. https://doi.org/10.1023/b:jogc.0000035523.96133.bc

Article  PubMed  PubMed Central  Google Scholar 

Dheensa S, Lucassen A, Fenwick A (2017) Limitations and pitfalls of using family letters to communicate genetic risk: a qualitative study with patients and healthcare professionals. J Genet Couns 27(3):689–701. https://doi.org/10.1007/s10897-017-0164-x

Article  PubMed  PubMed Central  Google Scholar 

Di Pietro ML, Zaçe D, Orfino A, Di Raimo FR, Poscia A, de Matteis E, Turchetti D, Godino L, Bertonazzi B, Franiuk M, Bruzzone C, Varesco L, Lucci-Cordisco E, Genuardi M (2020) Correction: intrafamilial communication of hereditary breast and ovarian cancer genetic information in Italian women: towards a personalised approach. Eur J Hum Genet 29(2):362–362. https://doi.org/10.1038/s41431-020-00733-5

Article  PubMed Central  Google Scholar 

Dinh T, Rosner B, Atwood J, Boland C, Syngal S, Vasen H et al (2010) Health benefits and cost-effectiveness of primary genetic screening for Lynch Syndrome in the General Population. Cancer Prev Res 4(1):9–22. https://doi.org/10.1158/1940-6207.capr-10-0262

Article  Google Scholar 

Etchegary H, Pullman D, Simmonds C, Rabie Z, Rahman P (2021) Identifying aspects of Public Attitudes toward Whole Genome Sequencing to Inform the Integration of Genomics into Care. Public Health Genomics 24(5–6):229–240. https://doi.org/10.1159/000515952

Article  PubMed  Google Scholar 

Fogleman A, Zahnd W, Lipka A, Malhi R, Ganai S, Delfino K, Jenkins W (2019) Knowledge, attitudes, and perceived barriers towards genetic testing across three rural Illinois communities. J Community Genet 10(3):417–423. https://doi.org/10.1007/s12687-019-00407-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forrest K, Simpson S, Wilson B, Van Teijlingen E, McKee L, Haites N, Matthews E (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64(4):317–326. https://doi.org/10.1034/j.1399-0004.2003.00142.x

Article  CAS  PubMed  Google Scholar 

Frey MK, Kahn RM, Lipkin K, Chapman-Davis E, Jordan B, Tubito F, Pires M, Ram-Junnarkar S, Caputo TA, Holcomb KM (2019) Cascade genetic testing for cancer-associated germline mutations: patient-reported anxiety and uncertainty regarding communication with family members. Gynecol Oncol 154:280. https://doi.org/10.1016/j.ygyno.2019.04.660

Article  Google Scholar 

Garber J, Offit K (2005) Hereditary Cancer Predisposition syndromes. J Clin Oncol 23(2):276–292. https://doi.org/10.1200/jco.2005.10.042

Article  PubMed  Google Scholar 

Gupta S, Provenzale D, Regenbogen S, Hampel H, Slavin T, Hall M et al (2017) J Natl Compr Canc Netw 15(12):1465–1475. https://doi.org/10.6004/jnccn.2017.0176. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017

Guzauskas G, Garbett S, Zhou Z, Spencer S, Smith H, Hao J et al (2020) Cost-effectiveness of Population-wide genomic screening for Hereditary breast and ovarian Cancer in the United States. JAMA Netw Open, 3(10), e2022874

Haas CB, Scrol A, Jujjavarapu C, Jarvik GP, Henrikson NB (2021) Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. Integrated Health System: a qualitative approach from user-testing. Health Policy Technol 10(2):100511. https://doi.org/10.1016/j.hlpt.2021.100511

Article  PubMed  PubMed Central  Google Scholar 

Haga S, Burke W, Agans R (2013) Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine? Genet Sci 15(7):513–514. https://doi.org/10.1038/gim.2012.168

Article  Google Scholar 

Hakonarson H, Gulcher J, Stefansson K (2003) deCODE genetics, Inc. Pharmacogenomics 4(2):209–215. https://doi.org/10.1517/phgs.4.2.209.22627

Article  PubMed  Google Scholar 

Henrikson N, Blasi P, Figueroa Gray M, Tiffany B, Scrol A, Ralston J et al (2021) Patient and family preferences on Health System-Led Direct Contact for Cascade Screening. J Personalized Med 11(6):538. https://doi.org/10.3390/jpm11060538

Article  Google Scholar 

Hinchcliff E, Bednar E, Lu K, Rauh-Hain J (2019) Disparities in gynecologic cancer genetics evaluation. Gynecol Oncol 153(1):184–191. https://doi.org/10.1016/j.ygyno.2019.01.024

Article  PubMed  PubMed Central  Google Scholar 

Hodgson J, Metcalfe S, Aitken M, Donath S, Gaff C, Winship I et al (2014) Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention. BMC Med Genet 15(1). https://doi.org/10.1186/1471-2350-15-33

Hynes J, MacMillan A, Fernandez S, Jacob K, Carter S, Predham S, Etchegary H, Dawson L (2020) Group plus Mini individual pre-test genetic counselling sessions for hereditary cancer shorten provider time and improve patient satisfaction. Hereditary Cancer Clin Pract 18(1). https://doi.org/10.1186/s13053-020-0136-2

Lambert D, Patrinos D, Knoppers B, Zawati M (2021) Genetic counselors and legal recognition: a made-for‐Canada approach. J Genet Couns 31(1):49–58. https://doi.org/10.1002/jgc4.1468

Article  PubMed  PubMed Central  Google Scholar 

Legislative Summary of Bill S-201: An Act to prohibit and prevent genetic discrimination (2022) Retrieved 19 April 2022, from https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/421S201E

Leonard T, Hughes AE, Pruitt SL (2016) Understanding how low–socioeconomic status households cope with health shocks. ANNALS Am Acad Political Social Sci 669(1):125–145. https://doi.org/10.1177/0002716216680989

Article  Google Scholar 

Loader S, Shields C, Levenkron J, Fishel R, Rowley P (2002) Patient vs. physician as the Target of Educational Outreach about Screening for an inherited susceptibility to Colorectal Cancer. Genet Test 6(4):281–290. https://doi.org/10.1089/10906570260471813

Article  PubMed  Google Scholar 

Lowery J, Axell L, Vu K, Rycroft R (2010) A novel approach to increase awareness about hereditary colon cancer using a state cancer registry. Genet Sci 12(11):721–725. https://doi.org/10.1097/gim.0b013e3181f1366a

Article  Google Scholar 

Lucassen A, Hall A (2019) Consent and confidentiality in clinical genetic practice: Guidance on genetic testing and sharing genetic information. Clin Med 12(3):25–29 ISBN 978-1-86016-761-4

Comments (0)

No login
gif